A summary of research from the 2018 Australasian MND Symposium. This information will be of interest to neurologists and researchers with an interest in MND, and people affected by MND who have a strong interest in scientific research. This update discusses the early 2018 drug development pipeline and our current understanding of the disease mechanisms … Read more

A proposed staging system for MND

A summary of research from the 2018 Australasian MND Symposium. This information will be of interest to people with MND, their carers and health professionals. Below is a broad update about developments in research towards a cure and understanding the causes of MND, including a proposed staging system for MND (similar to that used for … Read more

A summary of research from the 2018 Australasian MND Symposium, regarding the clinical management of MND. This information will be of interest to allied health professionals who work with people with MND in New Zealand. It includes advice about communicating about sensitive subjects, new respiratory research, and developments in assistive communication technology. 1. Clinical Management … Read more

Assisted dying (definition)

MND New Zealand appreciates that many people in our community have strong views about assisted dying, both in favour and against. We choose to remain neutral as an organisation, but made a submission to the Select Committee to ensure that any rights that could be created by the End of Life Choice Bill do not … Read more

Australasian MND Symposium 2018 - day 3

Live updates from the Australasian MND Symposium, March 23, 2018. Written by a non-scientist for a layperson audience. This means we’re skipping the complicated science and going straight for the highlights. Typing fast and editing slow, so excuse spelling mistakes. UPDATES FROM AUSTRALIA AND THE WORLD 8:45am Carol Birks (CEO, MND Australia) – 10 years … Read more

Australasian MND Symposium 2018 - day 2

Live updates from the Australasian MND Symposium, March 23, 2018. Written by a non-scientist for a layperson audience. This means we’re skipping the complicated science and going straight for the highlights. Typing fast and editing slow, so excuse spelling mistakes. DRUG DEVELOPMENT AND CLINICAL TRIAL DESIGN SESSION 8:30am Dr Lucie Bruijn – Opportunities and Advances … Read more

Live updates from the Australasian MND Symposium, March 22, 2018. Written by a non-scientist for a layperson audience. This means we’re skipping the complicated science and going straight for the highlights. Typing fast and editing slow, so excuse spelling mistakes. The team from MND New Zealand are at the inaugural Australasian MND Symposium hosted by … Read more

Cannabis sativa plant

We are please to introduce the ‘Review of Current Research Regarding the use of Medicinal Cannabis for MS and MND Symptom Management’, jointly commissioned by Multiple Sclerosis NZ and MND New Zealand. The review suggests that medicinal cannabis can provide some relief from pain and spasticity for people with MND. There are also risks involved. … Read more

NZ MND Research Network website

We are thrilled to announce that the website of the New Zealand MND Research Network (www.mndresearch.auckland.ac.nz) launched on November 1st 2017. We are thrilled to announce that the website of the New Zealand MND Research Network (www.mndresearch.auckland.ac.nz) launched on November 1st 2017. The Research Network website’s purpose is to provide a central location informing others … Read more

Frame from the New Zealand MND Registry launch video

The New Zealand MND Registry was launched in May 2017, just 8 months after 4000 participants in the Walk 2 D’Feet MND fundraised to establish the Registry. The New Zealand Motor Neurone Disease Registry was launched on on Monday 22 May 2017, just eight months after 4000 participants in 14 fundraising walks all over New … Read more

The US Food and Drug Administration building

Edaravone is not yet available on prescription in New Zealand. MND New Zealand will keep our community informed about further developments and what they may mean for people with MND in New Zealand. This is what we know so far. On Friday 5 May, the US Food and Drug Administration (the FDA) announced its approval … Read more

Organically grown vegetables

New research has confirmed a link between pesticides and an increased risk of MND… but don’t panic and chuck out all your non-organic veggies just yet. It’s specifically to do with exposure at work to organochlorine pesticides, many of which are now banned (like DDT). Read more about this interesting line of research here.  Dr Belinda … Read more